Skip to main content
SpringerLink
Log in

Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial

  • Chapter
  • First Online:
Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19

Part of the book series: Advances in Experimental Medicine and Biology ((PMISB,volume 1412))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dourado D, Freire DT, Pereira DT, et al (2021) Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomed Pharmacother 139111578. https://doi.org/10.1016/j.biopha.2021.111578

  2. Lu R, Zhao X, Li J, et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565–574

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Shah AS, Wood R, Gribben C, et al (2020) Risk of hospital admission with coronavirus disease 2019 in healthcare workers and their households: nationwide linkage cohort study. BMJ 371. https://doi.org/10.1136/bmj.m3582

  4. World Health Organization (WHO) WHO coronavirus disease (COVID-19) dashboard. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed September 19, 2022

  5. Mathieu E, Ritchie H, Ortiz-Ospina E, et al (2021) A global database of COVID-19 vaccinations. Nat Hum Behav 5(7):947–953

    Article  PubMed  Google Scholar 

  6. Shek DT (2021) COVID-19 and quality of life: Twelve reflections. Appl Res Qual Life 16(1):1–11

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wojcieszyńska D, Guzik H, Guzik U (2022) Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment. Sci Total Environ; 834:155317. https://doi.org/10.1016/j.scitotenv.2022.155317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Vahedian-Azimi A, Abbasifard M, Rahimi-Bashar F, et al (2022) Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials. Nutrients 14(2). https://doi.org/10.3390/nu14020256

  9. Canoğlu K, Şaylan B, Çalışkan T (2021) COVID-19 and thrombosis: Prophylaxis and management. Tuberk Toraks 69(2):269–278

    Article  PubMed  Google Scholar 

  10. Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. J Med Virol 93(1):250–256

    Article  CAS  PubMed  Google Scholar 

  11. Conti P, Ronconi G, Caraffa A, et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2):327–331

    CAS  PubMed  Google Scholar 

  12. Vitiello A, La Porta R, D’Aiuto V, Ferrara F (2021) The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egypt Liver J 11(1):11. https://doi.org/10.1186/s43066-021-00082-y

    Article  PubMed  PubMed Central  Google Scholar 

  13. Yuan X, Huang W, Ye B, et al (2020) Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol 112(4):553–559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Momtazi-Borojeni AA, Haftcheshmeh SM, Esmaeili SA, et al (2018) Curcumin: A natural modulator of immune cells in systemic lupus erythematosus. Autoimmun Rev 17(2):125–135

    Article  CAS  PubMed  Google Scholar 

  15. Iranshahi M, Sahebkar A, Takasaki M, et al (2009) Cancer chemopreventive activity of the prenylated coumarin, umbelliprenin, in vivo. Eur J Cancer Prev 18(5):412–415

    Article  CAS  PubMed  Google Scholar 

  16. Panahi Y, Ghanei M, Bashiri S, et al (2014) Short-term Curcuminoid Supplementation for Chronic Pulmonary Complications due to Sulfur Mustard Intoxication: Positive Results of a Randomized Double-blind Placebo-controlled Trial. Drug Res 65(11):567–573

    Article  Google Scholar 

  17. Panahi Y, Khalili N, Sahebi E, et al (2017) Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial. Complement Ther Med 33:1–5

    Article  PubMed  Google Scholar 

  18. Parsamanesh N, Moossavi M, Bahrami A, et al (2018) Therapeutic potential of curcumin in diabetic complications. Pharmacol Res 136:181–193

    Article  CAS  PubMed  Google Scholar 

  19. Shah M, Murad W, Mubin S, et al (2022) Multiple health benefits of curcumin and its therapeutic potential. Environ Sci Pollut Res Int 29(29):43732–43744

    Article  CAS  PubMed  Google Scholar 

  20. Gorabi AM, Kiaie N, Hajighasemi S, et al (2019) The effect of curcumin on the differentiation of mesenchymal stem cells into mesodermal lineage. Molecules 24(22):4029. https://doi.org/10.3390/molecules24224029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mohajeri M, Bianconi V, Ávila-Rodriguez MF, et al (2020) Curcumin: a phytochemical modulator of estrogens and androgens in tumors of the reproductive system. Pharmacol Res 156:104765. https://doi.org/10.1016/j.phrs.2020.104765

    Article  CAS  PubMed  Google Scholar 

  22. Hassaniazad M, Eftekhar E, Inchehsablagh BR, et al (2021) A triple-blind, placebo-controlled, randomized clinical trial to evaluate the effect of curcumin-containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID-19 patients. Phytother Res 35(11):6417–6427

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Kunnumakkara AB, Rana V, Parama D, et al (2021) COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci 284:119201. https://doi.org/10.1016/j.lfs.2021.119201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Peng Y, Ao M, Dong B, et al (2021) Anti-Inflammatory Effects of Curcumin in the Inflammatory Diseases: Status, Limitations and Countermeasures. Drug Des Devel Ther 15:4503–4525

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Zahedipour F, Hosseini SA, Sathyapalan T, et al (2020) Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res 34(11):2911–2920

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Heidari Z, Daei M, Boozari M, et al (2022) Curcumin supplementation in pediatric patients: A systematic review of current clinical evidence. Phytother Res 36(4):1442–1458

    Article  CAS  PubMed  Google Scholar 

  27. Goel A, Kunnumakkara AB, Aggarwal BB (2008)Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 75(4):787–809

    Article  CAS  PubMed  Google Scholar 

  28. Minassi A, Sánchez-Duffhues G, Collado JA, et al (2013) Dissecting the pharmacophore of curcumin. Which structural element is critical for which action? J Nat Prod 76(6):1105–1112

    Article  CAS  PubMed  Google Scholar 

  29. Boroumand N, Samarghandian S, Hashemy SI (2018) Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. J Herbmed Pharmacol 7(4):211–219

    Article  CAS  Google Scholar 

  30. Askari G, Sahebkar A, Soleimani D, et al (2022) The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial. Trials 23(1):472. https://doi.org/10.1186/s13063-022-06375-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hassanzadeh S, Read MI, Bland AR, et al (2020) Curcumin: an inflammasome silencer. Pharmacol Res 159:104921. https://doi.org/10.1016/j.phrs.2020.104921

    Article  CAS  Google Scholar 

  32. Farhood B, Mortezaee K, Goradel NH, et al (2019) Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy. J Cell Physiol 234(5):5728–5740

    Article  CAS  PubMed  Google Scholar 

  33. Rinwa P, Kumar A (2012) Piperine potentiates the protective effects of curcumin against chronic unpredictable stress-induced cognitive impairment and oxidative damage in mice. Brain Res 1488:38–50

    Article  CAS  PubMed  Google Scholar 

  34. Li Q, Zhai W, Jiang Q, et al (2015) Curcumin–piperine mixtures in self-microemulsifying drug delivery system for ulcerative colitis therapy. International Journal of Pharmaceutics 490(1):22–31

    Article  CAS  PubMed  Google Scholar 

  35. Askari G, Alikiaii B, Soleimani D, et al (2021) Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial. Trials 22(1):434. https://doi.org/10.1186/s13063-021-05372-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Honarkar Shafie E, Taheri F, Alijani N, et al (2022) Effect of nanocurcumin supplementation on the severity of symptoms and length of hospital stay in patients with COVID-19: A randomizd double-blind placebo-controlled trial. Phytother Res 36(2):1013–1022

    Article  CAS  PubMed  Google Scholar 

  37. Pawar KS, Mastud RN, Pawar SK, et al (2021) Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial. Front Pharmacol 12:669362. https://doi.org/10.3389/fphar.2021.669362

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Ahmadi R, Salari S, Sharifi MD, et al (2021) Oral nano-curcumin formulation efficacy in the management of mild to moderate outpatient COVID-19: A randomized triple-blind placebo-controlled clinical trial. Food Sci Nutr 9(8):4068–4075

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Asadirad A, Nashibi R, Khodadadi A, et al (2022) Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial. Phytother Res 36(2):1023–1031

    Article  CAS  PubMed  Google Scholar 

  40. Valizadeh H, Abdolmohammadi-Vahid S, Danshina S et al (2020) Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. Int Immunopharmacol 89(Pt B):107088. https://doi.org/10.1016/j.intimp.2020.107088

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Lei F, Liu YM, Zhou F, et al (2020) Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology 72(2):389–398

    Article  CAS  PubMed  Google Scholar 

  42. Wijarnpreecha K, Ungprasert P, Panjawatanan P, et al (2021) COVID-19 and liver injury: a meta-analysis. Eur J Gastroenterol Hepatol 33(7):990–995

    Article  CAS  PubMed  Google Scholar 

  43. Chen LZ, Lin ZH, Chen J, et al (2020) Can elevated concentrations of ALT and AST predict the risk of ’recurrence’ of COVID-19? Epidemiol Infect 148:e218 https://doi.org/10.1017/s0950268820002186

    Article  CAS  PubMed  Google Scholar 

  44. Jalali M, Mahmoodi M, Mosallanezhad Z, et al (2020) The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 48:102283. https://doi.org/10.1016/j.ctim.2019.102283

    Article  PubMed  Google Scholar 

  45. Mansour-Ghanaei F, Pourmasoumi M, Hadi A, Joukar F (2019) Efficacy of curcumin/turmeric on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review of randomized controlled trials. Integr Med Res 8(1):57–61

    Article  PubMed  Google Scholar 

  46. Xu G, Gu Y, Yan N, et al (2021) Curcumin functions as an anti-inflammatory and antioxidant agent on arsenic-induced hepatic and kidney injury by inhibiting MAPKs/NF-κB and activating Nrf2 pathways. Environ Toxicol 36(11):2161–2173

    Article  CAS  PubMed  Google Scholar 

  47. Zhong W, Qian K, Xiong J, et al (2016) Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-κB related signaling. Biomed Pharmacother 83:302–313

    Article  CAS  PubMed  Google Scholar 

  48. Zhou F, Xia J, Yuan HX, et al (2021) Liver injury in COVID-19: Known and unknown. World J Clin Cases 9(19):4980–4989

    Article  PubMed  PubMed Central  Google Scholar 

  49. Nogueira SÁ R, Oliveira SCS, Carvalho AFM, et al (2020) Renal changes and acute kidney injury in covid-19: a systematic review. Rev Assoc Med Bras (1992) 66Suppl 2(Suppl 2):112–117

    Article  PubMed  Google Scholar 

  50. Qu J, Zhu HH, Huang XJ, et al (2021) Abnormal Indexes of Liver and Kidney Injury Markers Predict Severity in COVID-19 Patients. Infect Drug Resist 14:3029–3040

    Article  PubMed  PubMed Central  Google Scholar 

  51. Huang Y, Tu M, Wang S, et al (2020) Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Med Infect Dis 36:101606. https://doi.org/10.1016/j.tmaid.2020.101606

    Article  PubMed  PubMed Central  Google Scholar 

  52. Fouad SH, Allam MF, Taha SI, et al (2021) Comparison of hemoglobin level and neutrophil to lymphocyte ratio as prognostic markers in patients with COVID-19. J Int Med Res 49(7):3000605211030124. https://doi.org/10.1177/03000605211030124

    Article  CAS  PubMed  Google Scholar 

  53. Taneri PE, Gómez-Ochoa SA, et al (2020) Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur J Epidemiol 35(8):763–773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Simple Plex™; Bio-Techne; Minneapolis, MN, USA. https://www.bio-techne.com/instruments/simple-plex

  55. Cytokine Array – Human Cytokine Antibody Array (Membrane, 42 Targets) (ab133997); Abcam; Cambridge, United Kingdom. https://www.abcam.com/cytokine-array%2D%2Dhuman-cytokine-antibody-array-membrane-42-targets-ab133997.html

  56. LEGENDplexTM Human Inflammation Panel 1 multiplex immunoassay. BioVendor; Brno, Czechia. https://www.biolegend.com/nl-be/products/legendplex-human-inflammation-panel-1-13-plex-with-v-bottom-plate-16929

  57. Multiplex Cytokine Assays with Luminex; Redwood City, CA, USA. https://www.precisionformedicine.com/specialty-lab-services/cytokine-analysis/luminex/

Download references

Acknowledgments

This study was approved and funded by Isfahan University of Medical Sciences with grant number 299197.

Competing Interests

MM is the founder of Sami-Sabinsa group of companies.

Author information

Authors and Affiliations

  1. Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran

    Gholamreza Askari, Mohammad Bagherniya, Zahra Kiani, Mehrnaz Shojaei, Shirin Hassanizadeh & Mahdi Vajdi

  2. Anesthesia and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

    Gholamreza Askari, Mohammad Bagherniya, Babak Alikiaii & Mahdiye Mirjalili

  3. Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

    Awat Feizi

  4. Sabinsa Corporation, East Windsor, NJ, USA

    Muhammed Majeed

  5. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhossein Sahebkar

  6. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhossein Sahebkar

  7. Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

    Amirhossein Sahebkar

Authors
  1. Gholamreza Askari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammad Bagherniya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zahra Kiani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Babak Alikiaii
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mahdiye Mirjalili
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mehrnaz Shojaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shirin Hassanizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mahdi Vajdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Awat Feizi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Muhammed Majeed
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Amirhossein Sahebkar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Campinas, Campinas, São Paulo, Brazil

    Paul C. Guest

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Askari, G. et al. (2023). Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial. In: Guest , P.C. (eds) Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19. Advances in Experimental Medicine and Biology(), vol 1412. Springer, Cham. https://doi.org/10.1007/978-3-031-28012-2_22

Download citation

Publish with us

Policies and ethics

Search

Navigation